• COVID Symptoms Rarely Rebound After Paxlovid Treatment: Study

    Despite worries that COVID-19 symptoms can return after patients take the drug Paxlovid, such cases of rebound symptoms are actually rare, a new study shows. In an advisory last month, the U.S. Centers for Disease Control and...

    • Posted June 14, 2022
    • 16
  • Health Highlights: June 14, 2022​

    Stress can age, weaken your immune system. New research shows that traumatic events, job strain, daily stressors and discrimination may all speed aging of the immune system, raising the risk for cancer, heart disease and other illnesses,...

    • Posted June 14, 2022
    • 14
  • Life Span of Native Americans Fell by Almost 5 Years During Pandemic

    In yet another sign that the pandemic has exacerbated disparities in health care, researchers report that the life expectancy of Native Americans plummeted by nearly five years as the new coronavirus raged across the country. The loss...

    • Posted June 14, 2022
    • 7
  • Weekend Binge Drinking: Not as Harmless as You Think

    Many may consider an episode of binge drinking — defined as 5 or more drinks on one occasion — as just being harmless fun. But a new study suggests that even moderate drinkers who indulge in binge...

    • Posted June 13, 2022
    • 1
  • Experimental Drug May Ease Hot Flashes

    Hot flashes are one of the most well-known symptoms of menopause and they can be severe and frequent, happening throughout the day and night over several years. Researchers say they have found a new, effective treatment that...

    • Posted June 13, 2022
    • 8
  • Another Study Finds Ivermectin Useless Against COVID-19

    Yet another study shows that ivermectin provides no benefits for COVID-19 patients, but researchers say they’ll continue to study a higher dose of the drug. Even though the drug used for parasitic infections in animals and people...

    • Posted June 13, 2022
    • 5
  • New ALS Drug Approved in Canada While Still Under FDA Review

    An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its effectiveness. A condition of...

    • Posted June 13, 2022
    • 3
  • ‘Forever Chemicals’ May Raise a Woman’s Blood Pressure

    Called “forever chemicals” because they linger in the environment, new research suggests that middle-aged women with high levels of perfluoroalkyls and polyfluoroalkyls (PFAS) in their blood may be more vulnerable to high blood pressure. In the study,...

    • Posted June 13, 2022
    • 3
  • AHA News: She Thought She Had Bronchitis, But the Problem Was Her Heart

    MONDAY, June 13, 2022 (American Heart Association News) — Terita Grier has struggled with obesity her whole life. She also has diabetes and high blood pressure, two leading risk factors for heart disease. Her dad died of...

    • Posted June 13, 2022
    • 8
  • Pfizer, Moderna COVID Shots Work for Kids Under 5, FDA Says

    Antibody levels suggest that three doses of Pfizer’s pediatric COVID vaccine help guard children under 5 against infection, a new analysis from the U.S. Food and Drug Administration shows. It was posted online Sunday ahead of an...

    • Posted June 13, 2022
    • 7